Lu-177-labeled PSMA ligands (Zentralklinik Bad Berka/Johns Hopkins University School of Medicine)

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameLu-177-labeled PSMA ligands (Zentralklinik Bad Berka/Johns Hopkins University School of Medicine)
Drug Alias NameLu-177-PSMA
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionProstate-Specific Membrane Antigen modulators
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsKidney NeoplasmsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesZentralklinik Bad Berka
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsKidney NeoplasmsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A